Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.


News Release

 View printer-friendly version

Charles River Laboratories Schedules 2007 Guidance Release and Conference Call

WILMINGTON, Mass., Nov 21, 2006 (BUSINESS WIRE) -- Charles River Laboratories International, Inc. (NYSE:CRL) will issue a press release to provide 2007 financial guidance on Wednesday, December 13, 2006, after the market closes. A conference call has been scheduled to discuss the guidance on Thursday, December 14, 2006, at 8:30 a.m. ET. An overview of Charles River's business and strategic focus will also be discussed.

Investors will have the opportunity to listen to a live webcast of the conference call through the Investor Relations section of the Company's website at A replay will be accessible through the same website approximately two hours following the conference call.

SOURCE: Charles River Laboratories International, Inc.

Investor Relations Contact:
Charles River Laboratories International, Inc.
Susan E. Hardy, 781-262-7616
Corporate Vice President, Investor Relations

Featured Report

2020 Annual Report (PDF)

Charles River Corporate Citizenship Report
View PDF
Print PDF